AN PHAT BIOPLASTICS |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10,050 VND | -0.50% |
|
+2.76% | +6.35% |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 2,516,640 | 2,174,240 | 3,193,344 | 6,593,977 | 2,610,935 | 3,612,494 |
| Enterprise Value (EV) 1 | 4,970,939 | 4,402,340 | 5,031,533 | 7,528,829 | 3,649,491 | 3,082,176 |
| P/E ratio | 13.2 x | 4.72 x | 11 x | 20.3 x | 15.8 x | 12.5 x |
| Yield | - | 7.87% | 3.47% | - | - | - |
| Capitalization / Revenue | 0.31 x | 0.23 x | 0.43 x | 0.5 x | 0.17 x | 0.29 x |
| EV / Revenue | 0.62 x | 0.48 x | 0.68 x | 0.57 x | 0.24 x | 0.24 x |
| EV / EBITDA | 7.8 x | 4.7 x | 7.85 x | 11 x | 7.55 x | 4.8 x |
| EV / FCF | -2.28 x | -6.8 x | 6.66 x | -74.7 x | -13.4 x | 3.19 x |
| FCF Yield | -43.9% | -14.7% | 15% | -1.34% | -7.46% | 31.3% |
| Price to Book | 0.98 x | 0.74 x | 0.89 x | 1.38 x | 0.47 x | 0.68 x |
| Nbr of stocks (in thousands) | 197,736 | 197,736 | 243,936 | 326,434 | 382,274 | 382,274 |
| Reference price 2 | 12,727 | 10,996 | 13,091 | 20,200 | 6,830 | 9,450 |
| Announcement Date | 3/18/19 | 3/19/20 | 3/29/21 | 3/31/22 | 3/31/23 | 4/1/24 |
1VND in Million2VND
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 8,011,573 | 9,258,073 | 7,428,557 | 13,143,110 | 15,290,297 | 12,621,514 |
| EBITDA 1 | 637,589 | 936,972 | 641,039 | 683,746 | 483,084 | 642,737 |
| EBIT 1 | 392,755 | 678,497 | 354,125 | 368,086 | 172,535 | 312,356 |
| Operating Margin | 4.9% | 7.33% | 4.77% | 2.8% | 1.13% | 2.47% |
| Earnings before Tax (EBT) 1 | 253,984 | 597,393 | 318,749 | 397,868 | 186,066 | 377,896 |
| Net income 1 | 180,260 | 460,466 | 262,241 | 290,241 | 152,599 | 289,411 |
| Net margin | 2.25% | 4.97% | 3.53% | 2.21% | 1% | 2.29% |
| EPS 2 | 965.2 | 2,329 | 1,191 | 993.7 | 433.0 | 757.0 |
| Free Cash Flow 1 | -2,179,970 | -647,189 | 755,114 | -100,784 | -272,276 | 964,690 |
| FCF margin | -27.21% | -6.99% | 10.17% | -0.77% | -1.78% | 7.64% |
| FCF Conversion (EBITDA) | - | - | 117.8% | - | - | 150.09% |
| FCF Conversion (Net income) | - | - | 287.95% | - | - | 333.33% |
| Dividend per Share | - | 865.8 | 454.5 | - | - | - |
| Announcement Date | 3/18/19 | 3/19/20 | 3/29/21 | 3/31/22 | 3/31/23 | 4/1/24 |
1VND in Million2VND
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 2,454,299 | 2,228,100 | 1,838,189 | 934,852 | 1,038,556 | - |
| Net Cash position 1 | - | - | - | - | - | 530,318 |
| Leverage (Debt/EBITDA) | 3.849 x | 2.378 x | 2.868 x | 1.367 x | 2.15 x | - |
| Free Cash Flow 1 | -2,179,970 | -647,189 | 755,114 | -100,784 | -272,276 | 964,690 |
| ROE (net income / shareholders' equity) | 9.21% | 15.7% | 7.78% | 6.84% | 2.02% | 5.1% |
| ROA (Net income/ Total Assets) | 4.06% | 5.47% | 2.67% | 2.48% | 1.04% | 1.74% |
| Assets 1 | 4,444,730 | 8,424,492 | 9,808,895 | 11,720,280 | 14,721,139 | 16,588,934 |
| Book Value Per Share 2 | 13,052 | 14,802 | 14,748 | 14,687 | 14,440 | 13,980 |
| Cash Flow per Share 2 | 3,264 | 1,475 | 3,951 | 6,091 | 4,298 | 6,370 |
| Capex 1 | 1,698,518 | 503,895 | 271,434 | 668,611 | 168,326 | 643,183 |
| Capex / Sales | 21.2% | 5.44% | 3.65% | 5.09% | 1.1% | 5.1% |
| Announcement Date | 3/18/19 | 3/19/20 | 3/29/21 | 3/31/22 | 3/31/23 | 4/1/24 |
1VND in Million2VND
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| +6.35% | 152M | |
| +3.89% | 14.46B | |
| +18.76% | 9.73B | |
| -12.66% | 6.82B | |
| +34.40% | 1.5B | |
| +10.24% | 1.37B | |
| -12.45% | 1.37B | |
| +30.43% | 1.28B | |
| -22.77% | 1.03B | |
| +20.36% | 851M |
- Stock Market
- Equities
- AAA Stock
- Financials An Phat Bioplastics
